Literature DB >> 10752958

Diffusion of high molecular weight compounds through sclera.

J Ambati1, C S Canakis, J W Miller, E S Gragoudas, A Edwards, D J Weissgold, I Kim, F C Delori, A P Adamis.   

Abstract

PURPOSE: To determine the in vitro permeability of the sclera to high molecular weight compounds and the relationship between scleral permeability and molecular size.
METHODS: Fresh rabbit sclera was mounted in a two-chamber diffusion apparatus, and its permeability to sodium fluorescein, fluorescein isothiocyanate (FITC)-conjugated bovine serum albumin, FITC-IgG, and FITC dextrans ranging in molecular weight from 4 to 150 kDa was determined by fluorescence spectrophotometry. Electron microscopy was used to assess the impact of the experimental design on scleral ultrastructural integrity. The effect of the diffusion apparatus on scleral hydration was examined. Rabbit scleral permeability was compared with previously reported data for human and bovine sclera.
RESULTS: Scleral permeability decreased with increasing molecular weight and molecular radius, consistent with previous human and bovine data. Molecular radius was a better predictor of scleral permeability than molecular weight. The sclera was more permeable to globular proteins than to linear dextrans of similar molecular weight. The experimental apparatus did not alter scleral ultrastructure. Permeability of rabbit sclera was similar to human sclera but greater than bovine sclera.
CONCLUSIONS: Large molecules, such as IgG, diffuse across sclera in a manner consistent with porous diffusion through a fiber matrix. Transscleral delivery of immunoglobulins and other large compounds to the choroid and retina may be feasible.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752958

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  75 in total

1.  Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.

Authors:  Samirkumar R Patel; Damian E Berezovsky; Bernard E McCarey; Vladimir Zarnitsyn; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-01       Impact factor: 4.799

2.  Thermomechanical stability of sclera after glyceraldehyde crosslinking.

Authors:  Gregor Wollensak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-18       Impact factor: 3.117

3.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

4.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

5.  Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery.

Authors:  Raghu Raj Singh Thakur; Steven J Fallows; Hannah L McMillan; Ryan F Donnelly; David S Jones
Journal:  J Pharm Pharmacol       Date:  2013-10-16       Impact factor: 3.765

6.  Relationship of stokes radius to the rate of diffusion across Bruch's membrane.

Authors:  Astrid Zayas-Santiago; Alan D Marmorstein; Lihua Y Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

7.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.

Authors:  Mary E Pease; Ericka N Oglesby; Elizabeth Cone-Kimball; Joan L Jefferys; Matthew R Steinhart; Anthony J Kim; Justin Hanes; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-21       Impact factor: 4.799

9.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

10.  Transscleral diffusion of ethacrynic acid and sodium fluorescein.

Authors:  Cheng-Wen Lin; Yong Wang; Pratap Challa; David L Epstein; Fan Yuan
Journal:  Mol Vis       Date:  2007-02-22       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.